Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Biotech
AbbVie in talks over $1B Gilgamesh buyout: report
AbbVie teamed up with Gilgamesh last year and is now reportedly in talks about buying the mental health biotech outright for about $1 billion.
Nick Paul Taylor
Jul 31, 2025 7:48am
Bausch Health bags phase 3-ready liver prospect in $63M buyout
Jul 29, 2025 9:35am
Sanofi inks $1.15B buyout to boost RSV pipeline
Jul 22, 2025 4:20am
ZimVie to be bought by ArchiMed in $730M deal
Jul 21, 2025 11:45am
iTeos, reeling from TIGIT fail, is latest prize for Concentra
Jul 21, 2025 9:36am
I-Mab buys Bridge Health for $3M to strengthen givastomig push
Jul 17, 2025 8:45am
